MedPath

Spanish Decision Tool for Ovarian Cancer Maintenance Therapy

Not Applicable
Recruiting
Conditions
Ovarian Cancer
Interventions
Other: Shared Medical Decision Tool
Behavioral: Engaging Patients in Decision Making
Behavioral: Literacy Spanish Language
Registration Number
NCT06036810
Lead Sponsor
M.D. Anderson Cancer Center
Brief Summary

To develop a shared decision-making (SDM) tool to help Spanish-speaking patients make decisions about their maintenance therapy

Detailed Description

Objectives:

* Create a low literacy version of a shared decision-making (SDM) tool for ovarian cancer maintenance therapy for Spanish speaking individuals.

* To explore the feasibility and acceptability of incorporating the SDM tool into routine clinical care for Spanish speaking individuals.

* To estimate the effectiveness of the SDM tool on quality of the decision making in patients with ovarian cancer who are making decisions about maintenance therapy through a pilot study.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
70
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Arm && Interventions
GroupInterventionDescription
Study Phase 1Shared Medical Decision ToolPre-testing and cognitive interviews for the Decision Support Tool
Study Phase 1Engaging Patients in Decision MakingPre-testing and cognitive interviews for the Decision Support Tool
Study Phase 2Shared Medical Decision ToolUsual Care (Control Group) or Participants utilize the Decision Support Tool with Provider guidance (Intervention Group).
Study Phase 1Literacy Spanish LanguagePre-testing and cognitive interviews for the Decision Support Tool
Study Phase 2Engaging Patients in Decision MakingUsual Care (Control Group) or Participants utilize the Decision Support Tool with Provider guidance (Intervention Group).
Study Phase 2Literacy Spanish LanguageUsual Care (Control Group) or Participants utilize the Decision Support Tool with Provider guidance (Intervention Group).
Primary Outcome Measures
NameTimeMethod
Decision Regret Scale questionnairethrough study completion; an average of 2 year.

This scale measures decisional regret related to health care decisions at a specific point in time. This tool consists of 5 questions answered on a Likert scale (1="Strongly agree" to 5="Strongly disagree").

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

M D Anderson Cancer Center

🇺🇸

Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath